ODERF(ODERF)
ODERF
No analyst ratings available
No analyst price targets available for ODERF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E | FY2030E | FY2031E |
|---|---|---|---|---|---|
| Revenue Avg | $453.69B | $472.51B | $492.40B | $522.68B | $554.86B |
| Low | $428.87B | $432.33B | $457.83B | $485.98B | $515.90B |
| High | $463.91B | $491.58B | $507.98B | $539.22B | $572.41B |
| EBITDA Avg | $188.62B | $196.45B | $204.72B | $217.31B | $230.68B |
| Low | $178.30B | $179.74B | $190.34B | $202.05B | $214.49B |
| High | $192.87B | $204.38B | $211.19B | $224.18B | $237.98B |
| EBIT Avg | $51.35B | $53.49B | $55.74B | $59.16B | $62.81B |
| Low | $48.54B | $48.94B | $51.82B | $55.01B | $58.40B |
| High | $52.51B | $55.64B | $57.50B | $61.04B | $64.79B |
| Net Income Avg | $39.10B | $42.07B | $49.93B | $51.04B | $57.21B |
| Low | $35.53B | $38.23B | $45.38B | $46.38B | $51.99B |
| High | $40.71B | $43.80B | $51.99B | $53.14B | $59.56B |
| EPS Avg | $113.26 | $121.86 | $144.65 | $147.86 | $165.72 |
| Low | $102.92 | $110.73 | $131.44 | $134.36 | $150.59 |
| High | $117.92 | $126.87 | $150.60 | $153.94 | $172.53 |
| Analysts (Rev / EPS) | 6 / 1 | 5 / 1 | 2 / 1 | 2 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|
| Revenue Avg | $107.88B | $118.99B | $130.23B |
| Low | $106.69B | $117.67B | $128.78B |
| High | $109.98B | $121.30B | $132.76B |
| EBITDA Avg | $44.85B | $49.47B | $54.14B |
| Low | $44.36B | $48.92B | $53.54B |
| High | $45.72B | $50.43B | $55.19B |
| EBIT Avg | $12.21B | $13.47B | $14.74B |
| Low | $12.08B | $13.32B | $14.58B |
| High | $12.45B | $13.73B | $15.03B |
| Net Income Avg | — | — | — |
| Low | — | — | — |
| High | — | — | — |
| EPS Avg | — | — | — |
| Low | — | — | — |
| High | — | — | — |
| Analysts (Rev / EPS) | 3 / — | 2 / — | 1 / — |